Related references
Note: Only part of the references are listed.The performance of M and XL probes of FibroScan for the diagnosis of steatosis and fibrosis on a Brazilian nonalcoholic fatty liver disease cohort
Ana Carolina Cardoso et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2020)
Nonalcoholic Fatty Liver Disease 2020: The State of the Disease
Thomas G. Cotter et al.
GASTROENTEROLOGY (2020)
New drugs for non-alcoholic steatohepatitis
Ana-Carolina Cardoso et al.
LIVER INTERNATIONAL (2020)
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
Philip N. Newsome et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology
James Neuberger et al.
GUT (2020)
Diagnostic accuracy of FibroScan-AST score to identify non-alcoholic steatohepatitis with significant activity and fibrosis in Japanese patients with non-alcoholic fatty liver disease: Comparison between M and XL probes
Satoshi Oeda et al.
HEPATOLOGY RESEARCH (2020)
Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities
Francisco Idalsoaga et al.
FRONTIERS IN MEDICINE (2020)
Past, present and future perspectives in nonalcoholic fatty liver disease
Arun J. Sanyal
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease
Laurent Castera et al.
GASTROENTEROLOGY (2019)
Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Zobair M. Younossi et al.
HEPATOLOGY (2018)
Controlled Attenuation Parameter (CAP) with the XL Probe of the FibroscanA®: A Comparative Study with the M Probe and Liver Biopsy
Victor de Ledinghen et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Fibrosis Stage Is the Strongest Predictor for Disease-Specific Mortality in NAFLD After Up to 33 Years of Follow-Up
Mattias Ekstedt et al.
HEPATOLOGY (2015)
Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Yoshio Sumida et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Liver Stiffness Measurement Using XL Probe in Patients With Nonalcoholic Fatty Liver Disease
Vincent Wai-Sun Wong et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: Comparison between M and XL probe of FibroScan®
Victor de Ledinghen et al.
JOURNAL OF HEPATOLOGY (2012)
Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography
Victor de Ledinghen et al.
LIVER INTERNATIONAL (2012)
Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
Christopher D. Williams et al.
GASTROENTEROLOGY (2011)
Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population
Grace L-H Wong et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Nonalcoholic fatty liver disease in Brazil. Clinical and histological profile
Helma P. Cotrim et al.
ANNALS OF HEPATOLOGY (2011)
Transient elastography with a new probe for obese patients for non-invasive staging of non-alcoholic steatohepatitis
Mireen Friedrich-Rust et al.
EUROPEAN RADIOLOGY (2010)
Diagnosis of Fibrosis and Cirrhosis Using Liver Stiffness Measurement in Nonalcoholic Fatty Liver Disease
Vincent Wai-Sun Wong et al.
HEPATOLOGY (2010)
Feasibility of liver transient elastography with FibroScan® using a new probe for obese patients
Victor de Ledinghen et al.
LIVER INTERNATIONAL (2010)
CONTROLLED ATTENUATION PARAMETER (CAP): A NOVEL VCTE™ GUIDED ULTRASONIC ATTENUATION MEASUREMENT FOR THE EVALUATION OF HEPATIC STEATOSIS: PRELIMINARY STUDY AND VALIDATION IN A COHORT OF PATIENTS WITH CHRONIC LIVER DISEASE FROM VARIOUS CAUSES
Magali Sasso et al.
ULTRASOUND IN MEDICINE AND BIOLOGY (2010)
Epidemiology and Natural History of Non-Alcoholic Steatohepatitis
Curtis K. Argo et al.
CLINICS IN LIVER DISEASE (2009)
Assessment of fibrosis by transient elastography compared with liver biopsy and morphometry in chronic liver diseases
Grace Lai-Hung Wong et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD)
M. Yoneda et al.
DIGESTIVE AND LIVER DISEASE (2008)
Transient elastography (FibroScan)
V. de Ledinghen et al.
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE (2008)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease
SR Weston et al.
HEPATOLOGY (2005)
Color and genomic ancestry in Brazilians
FC Parra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Transient elastography: A new noninvasive method for assessment of hepatic fibrosis
L Sandrin et al.
ULTRASOUND IN MEDICINE AND BIOLOGY (2003)
The ancestry of Brazilian mtDNA lineages
J Alves-Silva et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
Prevalence of and risk factors for hepatic steatosis in northern Italy
S Bellentani et al.
ANNALS OF INTERNAL MEDICINE (2000)
Share Paper
